Skip to content

Milestones

December 2025
Exploration Agreement Announced Under Strategic Partnership with Pfizer

Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer

November 2025
First Agreements Announced Under Collaboration with GSK

Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK

October 2025
Exploration Agreement Announced Under Strategic Partnership with Pfizer

Expedition Medicines Launches with Multi-target Exploration Agreement in Prostate Cancer Initiated Under Flagship's Strategic Partnership with Pfizer

September 2025
Flagship Pioneering Appoints Mary Beth Harler President of Pioneering Medicines

Dr. Harler Joins to Lead Effort to Create New Medicines Built from Flagship’s Innovative Bioplatforms and Novel Modalities

April 2025
Exploration Agreement Announced Under Strategic Partnership with Pfizer

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease

November 2024
Additional Exploration Agreements Announced Under Strategic Partnership with Pfizer

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer

August 2024
New Exploration Agreements Announced Under Strategic Partnership with Pfizer

Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer

July 2024
Flagship and GSK Announce Strategic Collaboration

GSK and Flagship Pioneering partner to discover novel medicines and vaccines

June 2024
First Exploration Agreement Announced Under Strategic Partnership with Pfizer

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer

May 2024
Research Collaboration Agreement Announced with Novo Nordisk

Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management

January 2024
First Two Research Collaboration Agreements Announced with Novo Nordisk

Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases

July 2023
Flagship and Pfizer Announce Strategic Alliance

Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs

July 2023
Pioneering Medicines Expands into New Office and Lab Space at One Charles Park
55k Sq.ft. Office and Lab Space Purpose-Built to Support Growth of In-house Drug Development Unit
May 2022
Flagship and Novo Nordisk Announce Strategic Collaboration

Novo Nordisk and Flagship Pioneering announce a strategic collaboration to create a portfolio of transformational medicines

November 2021
Pioneering Medicines Appoints Chief Technology Officer

Vaithianathan "Palani" Palaniappan Joins to Lead Strategy and Implementation of Chemistry, Manufacturing and Controls (CMC)

November 2021
Pioneering Medicines Announces First Strategic Partnership with the Cystic Fibrosis Foundation

Pioneering Medicines, an initiative of Flagship Pioneering, Establishes First-of-its-Kind Partnership with Cystic Fibrosis Foundation to Develop Breakthrough Treatments for CF

January 2021
Flagship Launches Pioneering Medicines

Flagship's In-house Drug Development Unit will Discover and Develop New Medicines Built from Flagship's Innovative Platforms

November 2020
Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer

Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer

December 2019
Flagship Pioneering Strengthens Leadership With Appointment of Paul Biondi as Executive Partner

Flagship Pioneering Strengthens Leadership With Appointment of Paul Biondi as Executive Partner